ACI's 4th Annual Biosimilars Forum

715 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
715
On SlideShare
0
From Embeds
0
Number of Embeds
500
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • *
  • ACI's 4th Annual Biosimilars Forum

    1. 1. 1st 2nd3rd 4thJune 5-7, 2013 - AgendaTo learn more and register Click HereDrawing on 3 years of top-notch programming, ACI’s 4th Annual Biosimilarsprogram remains the industry’s leading legal and regulatory event.FTC Spotlight: Addressing the AntitrustConcerns Resulting from Follow-On LegislationSuzanne Drennon Munck, Counsel forIntellectual Property, Federal TradeCommission.Insights from over 20 companies including a keynoteaddress from Merck on Branding and PromotionalConsideration for Biosimilars.Industry insights into when the first applications willbe forthcoming from over two dozen companiesincluding Eli Lilly, Astra Zeneca, Genentech, and Pfizer.Keynote Address from: Denise Esposito , DeputyAssociate Director for Policy, Office of RegulatoryPolicy ( ORP), CDER Food & Drug Administration(FDA).AmericanConference.com/biosimilars

    ×